Related Experiment Video
Updated: Jun 25, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
TATA box polymorphisms in human gene promoters and associated hereditary pathologies
L K Savinkova1, M P Ponomarenko, P M Ponomarenko
1Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia. icg-adm@bionet.nsc.ru
Genetic variations in TATA box sequences, recognized by TATA-binding protein (TBP), influence gene transcription and are linked to various human diseases. Understanding these TATA box polymorphisms is crucial for disease research.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- TATA-binding protein (TBP) initiates transcription by binding to the TATA box in gene promoters.
- Variations in TATA box sequences and flanking regions can affect TBP binding affinity and transcriptional regulation.
- TATA box polymorphisms have been implicated in human hereditary diseases.
Purpose of the Study:
- To investigate the impact of TATA box polymorphisms on gene expression.
- To correlate TATA box variations with specific human pathologies.
- To categorize and analyze different types of TATA box mutations.
Main Methods:
- Literature review of TATA box polymorphisms in human gene promoters.
- Analysis of functional characteristics and manifestation mechanisms of TATA-box Single Nucleotide Polymorphisms (SNPs).
- Categorization of polymorphisms into four classes based on their effect on promoter activity.
Main Results:
- Approximately 40 TATA element polymorphisms in human gene promoters have been described.
- Polymorphisms can weaken, enhance, create, or abolish the TATA box.
- Examples link TATA box variations to severe conditions like thalassemia, cancer, and hypertension.
Conclusions:
- TATA box polymorphisms play a significant role in regulating gene expression in vivo.
- These genetic variations are associated with a range of human hereditary diseases.
- Further research into TATA box SNPs can elucidate disease mechanisms and inform therapeutic strategies.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Incomplete Dominance
The Eukaryotic Promoter Region
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Principles of Pharmacogenetics: Types of Genetic Variants

